Area of research
Pathology and Forensic Medicine · Epidemiology
Research interest
Research interests include Lymphoma Diagnosis and Treatment, Multiple and Secondary Primary Cancers, Acute Myeloid Leukemia Research, and Acute Lymphoblastic Leukemia research.
Dasatinib-Associated Chylothorax: A Review of Cases Reported to the FDA Adverse Event Reporting System and the Published Literature
Temporal patterns in US population‐based patient survival among adults treated with chemotherapy and/or immunotherapy for multiple myeloma, 2000–2020
Postmarket review of photosensitivity associated with select BRAF and MEK inhibitors
Postmarketing Cases of Erdafitinib‐Associated Skeletal Growth Toxicity Events in Pediatric Patients
Patterns of red blood cell utilization: Harnessing electronic health records data from the Information Standard for Blood and Transplant (ISBT) 128 system within the Biologics Effectiveness and Safety (BEST) initiative
Patterns of platelet use evaluated in <scp>EHR</scp> networks of the Biologics Effectiveness and Safety Initiative, 2012–2018
Risks of therapy-related hematologic neoplasms beyond myelodysplastic syndromes and acute myeloid leukemia.
Varicella zoster virus reactivation reported with isatuximab use
Hemolytic anemia following alectinib reported to the U.S. Food and Drug Administration Adverse Event Reporting System
Benzene exposure and risk of benzene poisoning in Chinese workers.
Uncovering the Genetic Etiology of the (Posttherapy) Broken Heart.
The bidirectional increased risk of B-cell lymphoma and T-cell lymphoma.
Cause-specific mortality following polycythemia vera, essential thrombocythemia, and primary myelofibrosis in the US population, 2001-2017.
Adverse events reported to the U.S. Food and Drug Administration Adverse Event Reporting System for tisagenlecleucel
Adverse Events Associated with Use of Digoxin Immune Fab Reported to the US Food and Drug Administration Adverse Event Reporting System, 1986–2019
Erythema multiforme, Stevens Johnson syndrome, and toxic epidermal necrolysis reported after vaccination, 1999–2017
Cause-specific mortality in individuals with lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, 2000-2016.
Potential underestimation of cerebrovascular events in the PROVENGE Registry for the Observation, Collection, and Evaluation of Experience Data
Post-licensure surveillance of trivalent adjuvanted influenza vaccine (aIIV3; Fluad), Vaccine Adverse Event Reporting System (VAERS), United States, July 2016–June 2018
Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
Case series of reports of pruritus and sipuleucel-T submitted to the Food and Drug Administration Adverse Event Reporting System
Benzene Exposure Response and Risk of Myeloid Neoplasms in Chinese Workers: A Multicenter Case–Cohort Study
A retrospective cohort study of cause‐specific mortality and incidence of hematopoietic malignancies in <scp>C</scp>hinese benzene‐exposed workers
Increased stomach cancer risk following radiotherapy for testicular cancer
Evolving risk of therapy-related acute myeloid leukemia following cancer chemotherapy among adults in the United States, 1975-2008
Risk of treatment-related esophageal cancer among breast cancer survivors